CytoDyn is a biotechnology company developing therapies to address cancer, HIV, and other autoimmune diseases. It provides Leronlimab, a monoclonal antibody, to be used as a platform drug for a variety of indications. The company aims to help patients with breast cancer, HIV, graft-versus-host disease (GvHD), and nonalcoholic steatohepatitis (NASH).